Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radioisotopes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06504147
What this trial is testing

Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery

Who this might be right for
Peritoneal CarcinomatosisOvarian Cancer
Oncoinvent Solutions AS 114
Early research (Phase 1)Looking for participantsNCT07197645
What this trial is testing

Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain

Who this might be right for
Bone PainMetastatic Bone TumorBone Metastases in Subjects With Advanced Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 33
Large-scale testing (Phase 3)Study completedNCT00006329
What this trial is testing

Comparison of Two Methods of Parathyroidectomy for Primary Hyperparathyroidism

Who this might be right for
Hyperparathyroidism
National Center for Research Resources (NCRR)
Testing effectiveness (Phase 2)Study completedNCT03732781
What this trial is testing

Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC

Who this might be right for
Peritoneal CarcinomaColorectal Carcinoma
Oncoinvent Solutions AS 47
Not applicableTemporarily pausedNCT01000181
What this trial is testing

Imaging 61CuATSM Uptake in Atherosclerotic Plaque Using PET-CT

Who this might be right for
Carotid Atherosclerosis
King's College London 10
Large-scale testing (Phase 3)Looking for participantsNCT06855095
What this trial is testing

Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial

Who this might be right for
Neuroendocrine TumorsNeuroendocrine Tumor Grade 1Neuroendocrine Tumor Grade 2+1 more
The Netherlands Cancer Institute 39
Not applicableUnknownNCT06435741
What this trial is testing

Molecular Imaging of Gastric Cancer Metastatic Lymph Nodes with 99mTc-3PRGD2 Probe.

Who this might be right for
Stomach NeoplasmLymph Node MetastasisRADIONUCLIDE IMAGING
Peking University Cancer Hospital & Institute 30
Not applicableUnknownNCT04833517
What this trial is testing

Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)

Who this might be right for
Prostate Cancer MetastaticCastration Resistant Prostatic CancerAdvanced Prostate Carcinoma
Universität des Saarlandes 500
Not applicableStudy completedNCT02894216
What this trial is testing

Qualitative Radionuclide Shuntography for Adult Patients With Suspected V-P Shunt Malfunction

Who this might be right for
Ventriculoperitoneal Shunt MalfunctionRadionuclide Shuntography
Far Eastern Memorial Hospital 69
Testing effectiveness (Phase 2)UnknownNCT04029428
What this trial is testing

Peptide Receptor Radionuclide Therapy in the Treatment of Advanced, Non-resectable and/or Symptomatic Tumors With SSTR Overexpression

Who this might be right for
Neuroendocrine Tumors
University of Warmia and Mazury 150
Not applicableEnded earlyNCT00486447
What this trial is testing

Perfusion Imaging and CT -Understanding Relative Efficacy

Who this might be right for
Coronary Artery Disease
GE Healthcare 249
Testing effectiveness (Phase 2)UnknownNCT04194125
What this trial is testing

Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer

Who this might be right for
Neuroendocrine Tumors
University of Warmia and Mazury 25
Large-scale testing (Phase 3)Active Not RecruitingNCT04919226
What this trial is testing

Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE

Who this might be right for
Neuroendocrine Tumors
ITM Solucin GmbH 259
Not applicableEnded earlyNCT00213642
What this trial is testing

Tc-99m Renography and Cisplatin-induced Nephrotoxicity

Who this might be right for
CancerDrug ToxicityKidney Failure
University Hospital, Rouen 20
Large-scale testing (Phase 3)WithdrawnNCT01860742
What this trial is testing

Randomized Phase III of PRRT Versus Interferon

Who this might be right for
Gastro-intestinal Neuroendocrine Tumors
Jules Bordet Institute
Testing effectiveness (Phase 2)Ended earlyNCT02488512
What this trial is testing

Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas

Who this might be right for
DLBCLMCLRecurrent Disease
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 1
Not applicableActive Not RecruitingNCT04769817
What this trial is testing

ProsTIC Registry of Men Treated With PSMA Theranostics

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate Cancer
Peter MacCallum Cancer Centre, Australia 500
Very early researchStudy completedNCT05871320
What this trial is testing

Novel 99mTc-labeled Somatostatin Antaginosts in the Diagnostic Algotithm of Neuroendocrine Neoplasms

Who this might be right for
Neuroendocrine Tumors
Jagiellonian University 10
Not applicableStudy completedNCT01880008
What this trial is testing

Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma

Who this might be right for
Glioblastoma
Washington University School of Medicine 5
Testing effectiveness (Phase 2)Looking for participantsNCT07595835
What this trial is testing

CT-guided Percutaneous Radionuclide Therapy With 32P Microparticles in Patients With Non-progressive Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
M.R. Meijerink 20
Next Page